Nisha Almeida is manager of the Health Technology Assessment Unit (TAU) of the MUHC. She holds a BSc in Molecular Biology and a PhD in Epidemiology and Biostatistics from McGill University. She has advanced training in epidemiological and biostatistical methods and specific experience in the evaluation and implementation of health technologies and interventions.
She was previously a senior epidemiologist at TAU, and led the implementation of hospital quality improvement initiatives while coordinating the participation of various stakeholders, data collection and analytical efforts. She played a key role in the development of a decision-aid tool to translate scientific evidence into hospital policy recommendations. Her work has been published in the peer-reviewed literature and she has been successful in securing funds for hospital initiatives. Nisha is particularly interested in harnessing hospital data to improve health outcomes and services.
James Brophy is the Chair of the Policy Committee of the Technology Assessment Unit of the McGill University Health Centre. He is a practicing cardiologist with a Ph.D. in Epidemiology and Biostatistics. He is a funded scholar from the Fonds de Recherche du Quebec (Santé) with a chair in health technology assessment and evidence-based medicine. His research interests center on cardiovascular epidemiology with a special interest in pharmacoepidemiology, outcomes research, medical decision making as well as health technology assessments, including economic analyses. He has published over 150 peer-reviewed articles. He is a full professor in the departments of medicine and epidemiology and biostatistics at McGill University.
Thiphavone Oudanonh is a Research Assistant at the Technology Assessment Unit of the McGill University Health Centre. She holds a BSc in Biochemistry and a Certificate in Quantitative Methods from UQAM as well as an MSc in Epidemiology from Laval University. Her main goal is to provide valid evidence to support health-related decisions.
Ian is a biostatistician with the Technology Assessment Unit and the Research Institute of the MUHC. He received his MSc in Statistics from the Université du Québec à Montréal (UQAM). His interests include Bayesian statistics, diagnostic test accuracy and developing R shiny apps. He teaches introductory statistics at UQAM.
Eva Suarthana is a Planning, Programming and Research Officer at the Health Technology Assessment Unit (TAU) of the McGill University Health Centre (MUHC). After graduating from the Faculty of Medicine at the University of Indonesia in Jakarta, she completed her master’s studies in Clinical Epidemiology at the Netherlands Institute for Health Sciences in Rotterdam, and her PhD at the Institute for Risk Assessment Sciences, University of Utrecht, in the Netherlands. She did her post-doc as an Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention (CDC) in the USA. Since moving to Canada, she has been working as a medical epidemiologist. She has written successful grant applications and has a strong publication record in public health and women’s health. Joining the TAU, she aims to support the evidence-based healthcare service and decision-making process for adopting new health technologies at the MUHC. She is an adjunct professor at McGill University and an associate investigator at the Research Institute of the MUHC.
Valerie is a Research Officer at the Technology Assessment Unit. She is completing her PhD at Concordia University and holds an MA in Ethics and Spirituality in End-of-Life Care. She is interested in contributing to improve contextual analysis through qualitative methods and in bridging theory and practice at various levels of organizational initiatives.